Burning Rock Biotech (BNR) Total Current Liabilities (2019 - 2026)

Burning Rock Biotech's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $33.3 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 4.23% year-over-year to $33.3 million; the TTM figure through Mar 2026 stood at $33.3 million (down 4.23% YoY), while the FY2025 annual figure was $35.3 million, down 3.2% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $33.3 million, down from $34.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $63.1 million in Q1 2022, with the low at $32.1 million in Q2 2025.
• The 5-year median for Total Current Liabilities is $36.8 million (2024), against an average of $42.2 million.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 50.2% in 2022, then plunged 36.77% in 2023.
• Burning Rock Biotech's Total Current Liabilities stood at $57.9 million in 2022, then slumped by 36.77% to $36.6 million in 2023, then grew by 1.35% to $37.1 million in 2024, then decreased by 6.07% to $34.8 million in 2025, then retreated by 4.32% to $33.3 million in 2026.
• Business Quant data shows BNR's Total Current Liabilities at $33.3 million in Q1 2026, $34.8 million in Q4 2025, and $33.0 million in Q3 2025.